Abstract

Objective: Several studies support a beneficial role of the dietary polyphenols in regulating some cardiovascular risk factors. The objective of our study was to examine the apple polyphenols’ proprieties. Design and method: This was a two-phases study. The in vitro experiment was carried out developing a sensitive method measuring the intracellular xantine oxidase [XO] activity and its inhibition due to drugs effectively able to cross the cell membrane. A reaction mixture without XO was used as negative control and one with several diluition of oxypurinol was used as positive control. The in vivo study consisted in a randomized, double-blind, parallel placebo-controlled clinical trial involving 60 volunteers withsuboptimal values of fasting plasma glucose (101 mg/dL < FPG < 126 mg/dL). The treatment period was 8 weeks long and consisted in an indistinguishable pill of placebo or an active product, containing 300 mg of apple polyphenol extract. Results: The inhibition degree of XO by apple polyphenols was IC50 = 154 ± 28 ng/mL. During the clinical trial, after the first four weeks of treatment, the FPG decreased in the active treated group (−6,1%, P < 0,05), while no significant changes were observed in both groups of treatment regarding the other hematochemistry parameters or the blood pressure values and the anthropometric characteristics (P > 0,05 always). After 8 weeks of treatment, the active-treated patients had an improvement in the FPG compared to the baseline (−10,3%, P < 0,001) and the placebo group (P < 0,001) and SUA significantly improved too (−14,0%, P < 0,05 vs baseline; P < 0,05 vs placebo). Also the endothelial reactivity increased in the actively treated subjects in comparison with the baseline (0,24 ± 0,09, P = 0,009) and the placebo-treated group (P < 0,05). Conclusions: In vivo, apple polyphenols have a positive effect on the vascular oxidative stress and the endothelium function and reduce FPG and uric acid by the inhibition of the XO, as our in vitro experiment attests.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call